Loading...

Marker Therapeutics, Inc.

MRKR•NASDAQ
Healthcare
Biotechnology
$1.66
$0.05(3.11%)
U.S. Market opens in 24h 7m

Marker Therapeutics, Inc. (MRKR) Stock Overview

Explore Marker Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.9M
P/E Ratio-2.11
EPS (TTM)$-0.79
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$1.44
3 Months$1.75
1 Year Target$1.78

MRKR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Marker Therapeutics, Inc. (MRKR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.11 and a market capitalization of 17.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.11%
5-Day Change
-3.49%
1-Month Change
22.06%
3-Month Change
-8.29%
6-Month Change
62.75%
Year-to-Date (YTD) Change
11.41%
1-Year Change
44.35%
3-Year Change
46.90%
5-Year Change
-91.31%
All-Time (Max) Change
-100.00%

Contact Information

https://www.markertherapeutics.com
713 400 6400
3200 Southwest Freeway, Houston, TX, 77027

Company Facts

5 Employees
IPO DateJul 16, 2002
CountryUS
Actively Trading

Frequently Asked Questions